Microglial morphological/inflammatory phenotypes and endocannabinoid signaling in a preclinical model of periodontitis and depression-Reference-Cited by-同舟云学术

Microglial morphological/inflammatory phenotypes and endocannabinoid signaling in a preclinical model of periodontitis and depression

Published:2024-09-08 Issue:1 Volume:21 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Robledo-Montaña Javier^ORCID,Díaz-García César^ORCID,Martínez María^ORCID,Ambrosio Nagore^ORCID,Montero Eduardo^ORCID,Marín María José^ORCID,Virto Leire^ORCID,Muñoz-López Marina^ORCID,Herrera David^ORCID,Sanz Mariano^ORCID,Leza Juan Carlos^ORCID,García-Bueno Borja^ORCID,Figuero Elena^ORCID,Martín-Hernández David^ORCID

Funder

MINECO-FEDER Funds

CIBERSAM/ISCIII

Santander-University Complutense of Madrid Projects

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12974-024-03213-5.pdf

Reference106 articles.

1. Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nat Reviews Disease Primers. 2016;2:16065.

2. GBD: Global Burden of Disease Study 2019. (GBD 2019) Results tool. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME); 2021.

3. World Health A. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level: report by the Secretariat. Geneva: World Health Organization; 2012.

4. Yuan K, Zheng YB, Wang YJ, Sun YK, Gong YM, Huang YT, Chen X, Liu XX, Zhong Y, Su SZ, et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27:3214–22.

5. Greenberg P, Chitnis A, Louie D, Suthoff E, Chen SY, Maitland J, Gagnon-Sanschagrin P, Fournier AA, Kessler RC. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019). Adv Ther 2023.